Dyne Therapeutics, Inc. Board of Directors

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Mr. John G. Cox M.B.A.

Mr. John G. Cox M.B.A.

CEO, President & Director

Ms. Johanna Friedl-Naderer

Ms. Johanna Friedl-Naderer

Chief Commercial Officer

Ms. Lucia Celona

Ms. Lucia Celona

Chief Human Resource Officer

Mr. Daniel Wilson

Mr. Daniel Wilson

Senior VP & Head of Legal

Dr. Ashish Dugar M.B.A., Ph.D.

Dr. Ashish Dugar M.B.A., Ph.D.

Chief Medical Affairs Officer

Ms. Debra Feldman

Ms. Debra Feldman

Chief Regulatory Affairs Officer

Dr. Oxana Beskrovnaya Ph.D.

Dr. Oxana Beskrovnaya Ph.D.

Chief Scientific Officer

Mr. Richard William Scalzo M.B.A.

Mr. Richard William Scalzo M.B.A.

Senior VP and Head of Finance & Administration

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.